These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16935100)

  • 1. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.
    Birim O; Kappetein AP; Waleboer M; Puvimanasinghe JP; Eijkemans MJ; Steyerberg EW; Versteegh MI; Bogers AJ
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):491-8. PubMed ID: 16935100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
    Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
    Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
    Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
    Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
    Ratto GB; Costa R; Maineri P; Alloisio A; Bruzzi P; Dozin B
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):849-58. PubMed ID: 19660370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of surgical treatment for non-small cell lung cancer with comorbid liver cirrhosis.
    Iwata T; Inoue K; Nishiyama N; Nagano K; Izumi N; Mizuguchi S; Morita R; Tsukioka T; Suehiro S
    Ann Thorac Surg; 2007 Dec; 84(6):1810-7. PubMed ID: 18036890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
    Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
    Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
    Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.
    Båtevik R; Grong K; Segadal L; Stangeland L
    Lung Cancer; 2005 Feb; 47(2):173-81. PubMed ID: 15639716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.